Results 231 to 240 of about 73,979 (245)

Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3)

Bioorganic and Medicinal Chemistry Letters, 2007
Adam Golebiowski, John C Vanrens, Michael P Clark   +2 more
exaly  

NOVEL COMPOUNDS FOR INHIBITION OF JANUS KINASE 1

2023
RAI SANTOSH KUMAR, BANDGAR MAHADEV, ALI SAZID, RAI HIMANSHU, GUNJAL AMOL PANDURANG, PATIL RAKESH ISWAR, BAPURAM SRINIVASA REDDY, KUMAR ANIL   +7 more
openaire   +1 more source

Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature

Journal of Dermatological Treatment, 2017
Alireza Firooz, Aniseh Samadi, Mansour Nassiri Kashani   +2 more
exaly  

Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs)

Bioorganic and Medicinal Chemistry Letters, 2009
Herbert R Treutlein, Emmanuelle Fantino, Tracy L Nero   +2 more
exaly  

Tricyclic Janus kinase 1 inhibitors, and compositions and methods thereof

2020
WAN ZHAOKUI, VAZQUEZ MICHAEL LAWRENCE
openaire   +9 more sources

Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure

Journal of the American Academy of Dermatology, 2017
James P Strassner, Brett King, John E Harris   +2 more
exaly  

Effects of Janus kinase inhibitor tofacitinib on circulating serum amyloid A and interleukin-6 during treatment for rheumatoid arthritis.

Clinical and Experimental Immunology, 2014
K Migita, M Izumi, Y Izumi
exaly  

Clinical significance of Janus Kinase inhibitor selectivity.

Rheumatology, 2019
Ernest Choy
exaly  

Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib

Journal of the American Academy of Dermatology, 2017
Victor Huang, Deep Joshipura, Alice B Gottlieb   +2 more
exaly  

Cooperative effects of Janus and Aurora kinase inhibition by CEP701 in cells expressing Jak2V617F

Journal of Cellular and Molecular Medicine, 2013
René Eulenfeld, Guy Berchem, Iris Behrmann   +2 more
exaly